Home > Animal Health & Nutrition > Veterinary Medical Devices > Veterinary Injectable Devices Market

Veterinary Injectable Devices Market Trends

Report ID: GMI6053
Published Date: Jun 2023
Report Format: PDF

Download Free Sample

Veterinary Injectable Devices Market Trends

The market is influenced by various trends that shape its dynamics. Some key trends in the industry includes increasing adoption of needle-free delivery systems, technological advancements in drug delivery, growing emphasis on using devices and techniques that minimize pain and stress during injections, and rising demand for customized and specialized injectables.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market for veterinary injectable devices was worth USD 879.1 million in 2022 and is expected to reach USD 1,418.3 million by 2032 driven by the increasing demand for veterinary healthcare and the rising need for disease prevention and management.

The syringes product segment held 29.3% share in the market and is estimated to depict significant growth through 2032 owing to the rising trend of pet ownership and the growing awareness of animal health.

North America industry is poised to grow at 4.7% CAGR from 2023 to 2032 attributed to the presence of well-developed veterinary infrastructure, including veterinary practices, hospitals, and clinics across the region.

Merck & Co., Inc., Hamilton Company, Neogen Corporation, Micrel Medical Devices SA, Serumwerk Bernburg AG, PBS Animal Health, Medtronic plc, Millpledge Pharmaceuticals, Terumo Medical Corporation, and Baxter International Inc. are among the top participants in the industry.